Search

Your search keyword '"Glucocorticoids -- Dosage and administration"' showing total 4 results
Start Over Descriptor "Glucocorticoids -- Dosage and administration" Topic asthma
4 results on '"Glucocorticoids -- Dosage and administration"'

1. Advair ([fluticasone propionate + salmeterol]; GlaxoSmithKline) Drug Overview 2018: A Fixed-Dose Combination of an Inhaled Corticosteroid and a Long-Acting Beta 2 Agonist - ResearchAndMarkets.com

Subjects
Fluticasone -- Dosage and administration, Combination drug therapy, Glucocorticoids -- Dosage and administration, Asthma, General interest, News, opinion and commentary, Advair Diskus (Medication)
Abstract

DUBLIN: Research and Markets has issued the following press release: -The 'Drug Overview: Advair' report has been added to ResearchAndMarkets.com's offering. Advair ([fluticasone propionate + salmeterol]; GlaxoSmithKline) is a fixed-dose [...]

Published
2018

2. Advair ([fluticasone propionate + salmeterol]; GlaxoSmithKline) Drug Overview 2018: A Fixed-Dose Combination of an Inhaled Corticosteroid and a Long-Acting Beta 2 Agonist - ResearchAndMarkets.com

Subjects
Fluticasone -- Dosage and administration, Combination drug therapy, Glucocorticoids -- Dosage and administration, Asthma, Business, Business, international, Advair Diskus (Medication)
Abstract

DUBLIN -- The 'Drug Overview: Advair' report has been added to ResearchAndMarkets.com's offering. Advair ([fluticasone propionate + salmeterol]; GlaxoSmithKline) is a fixed-dose combination of an inhaled corticosteroid (fluticasone propionate) and [...]

Published
2018

3. Advair ([fluticasone propionate + salmeterol]; GlaxoSmithKline) Drug Overview 2018: A Fixed-Dose Combination of an Inhaled Corticosteroid and a Long-Acting Beta 2 Agonist

Subjects
Fluticasone -- Dosage and administration, Combination drug therapy, Glucocorticoids -- Dosage and administration, Asthma, Business, Business, international
Abstract

M2 PRESSWIRE-May 14, 2018-: Advair ([fluticasone propionate + salmeterol]; GlaxoSmithKline) Drug Overview 2018: A Fixed-Dose Combination of an Inhaled Corticosteroid and a Long-Acting Beta 2 Agonist (C)1994-2018 M2 COMMUNICATIONS RDATE:14052018 [...]

Published
2018

4. New Findings from Medical Research Institute of New Zealand in the Area of Asthma Reported (Oral Steroid-sparing Effect of High-dose Inhaled Corticosteroids In Asthma)

Subjects
Medical research, Glucocorticoids -- Dosage and administration, Corticosteroid drugs -- Dosage and administration, Asthma, Lung diseases, Editors, Respiratory tract diseases, Health
Abstract

2020 JAN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- Current study results on Lung Diseases and Conditions - Asthma have been published. According [...]

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results